Glomerular & immune kidney disease
12 trialsAPPLAUSE-IgAN2025Iptacopan in Primary IgA NephropathyNefIgArd2023Nefecon in Patients with Primary IgA NephropathyPROTECT2023Sparsentan in IgA NephropathyDUPLEX2023Sparsentan in Focal Segmental GlomerulosclerosisAURORA 12021Voclosporin for Lupus Nephritis (AURORA 1)ADVOCATE2021Avacopan for ANCA-Associated VasculitisBLISS-LN2020Belimumab in Lupus NephritisPEXIVAS2020Plasma Exchange and Glucocorticoids in Severe ANCA-Associated VasculitisMENTOR2019Membranous Nephropathy Trial of RituximabRAVE2010Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisALMS2009Aspreva Lupus Management StudyPonticelli1984Ponticelli Regimen for Idiopathic Membranous Nephropathy